Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
Κύριοι συγγραφείς: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
Άλλοι συγγραφείς: | International College of Geriatric Psychoneuropharmacology |
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
John Wiley & Sons, Ltd.
2010
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
ανά: Oulhaj, A, κ.ά.
Έκδοση: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
ανά: Smith, A, κ.ά.
Έκδοση: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
ανά: de Jager, C, κ.ά.
Έκδοση: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
ανά: De Jager, C, κ.ά.
Έκδοση: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
ανά: Goodwin, G
Έκδοση: (2003)